Annual D&A
$5.36 M
+$224.00 K+4.36%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual depreciation & amortization is $5.36 million, with the most recent change of +$224.00 thousand (+4.36%) on December 31, 2023.
- During the last 3 years, TCRX annual D&A has risen by +$4.13 million (+335.85%).
- TCRX annual D&A is now at all-time high.
Performance
TCRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.03 M
-$89.00 K-7.97%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly depreciation & amortization is $1.03 million, with the most recent change of -$89.00 thousand (-7.97%) on September 30, 2024.
- Over the past year, TCRX quarterly D&A has dropped by -$259.00 thousand (-20.14%).
- TCRX quarterly D&A is now -31.49% below its all-time high of $1.50 million, reached on March 31, 2023.
Performance
TCRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$4.68 M
-$259.00 K-5.25%
September 30, 2024
Summary
- As of February 7, 2025, TCRX TTM depreciation & amortization is $4.68 million, with the most recent change of -$259.00 thousand (-5.25%) on September 30, 2024.
- Over the past year, TCRX TTM D&A has dropped by -$888.00 thousand (-15.96%).
- TCRX TTM D&A is now -15.96% below its all-time high of $5.57 million, reached on September 30, 2023.
Performance
TCRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TCRX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.4% | -20.1% | -16.0% |
| 3 y3 years | +335.9% | -20.1% | -16.0% |
| 5 y5 years | +933.0% | -20.1% | -16.0% |
TCRX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.1% | -31.5% | at low | -16.0% | +40.5% |
| 5 y | 5-year | at high | +933.0% | -31.5% | +362.6% | -16.0% | +2006.8% |
| alltime | all time | at high | +933.0% | -31.5% | +362.6% | -16.0% | +2006.8% |
TScan Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.03 M(-8.0%) | $4.68 M(-5.2%) |
| Jun 2024 | - | $1.12 M(-11.0%) | $4.94 M(-3.5%) |
| Mar 2024 | - | $1.25 M(-2.0%) | $5.12 M(-4.6%) |
| Dec 2023 | $5.36 M(+4.4%) | $1.28 M(-0.5%) | $5.36 M(-3.7%) |
| Sep 2023 | - | $1.29 M(-0.8%) | $5.57 M(+0.6%) |
| Jun 2023 | - | $1.30 M(-13.5%) | $5.53 M(+1.6%) |
| Mar 2023 | - | $1.50 M(+1.0%) | $5.44 M(+5.9%) |
| Dec 2022 | $5.14 M | $1.48 M(+18.6%) | $5.14 M(+7.1%) |
| Sep 2022 | - | $1.25 M(+3.6%) | $4.79 M(+4.2%) |
| Jun 2022 | - | $1.21 M(+1.0%) | $4.60 M(+13.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.20 M(+4.6%) | $4.05 M(+21.8%) |
| Dec 2021 | $3.33 M(+170.6%) | $1.14 M(+8.1%) | $3.33 M(+28.9%) |
| Sep 2021 | - | $1.06 M(+59.8%) | $2.58 M(+37.9%) |
| Jun 2021 | - | $661.00 K(+40.9%) | $1.87 M(+26.7%) |
| Mar 2021 | - | $469.00 K(+18.4%) | $1.48 M(+20.1%) |
| Dec 2020 | $1.23 M(+137.0%) | - | - |
| Dec 2020 | - | $396.00 K(+14.5%) | $1.23 M(+47.5%) |
| Sep 2020 | - | $346.00 K(+30.1%) | $834.00 K(+70.9%) |
| Jun 2020 | - | $266.00 K(+19.8%) | $488.00 K(+119.8%) |
| Mar 2020 | - | $222.00 K | $222.00 K |
| Dec 2019 | $519.00 K | - | - |
FAQ
- What is TScan Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for TScan Therapeutics?
- What is TScan Therapeutics annual D&A year-on-year change?
- What is TScan Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for TScan Therapeutics?
- What is TScan Therapeutics quarterly D&A year-on-year change?
- What is TScan Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for TScan Therapeutics?
- What is TScan Therapeutics TTM D&A year-on-year change?
What is TScan Therapeutics annual depreciation & amortization?
The current annual D&A of TCRX is $5.36 M
What is the all time high annual D&A for TScan Therapeutics?
TScan Therapeutics all-time high annual depreciation & amortization is $5.36 M
What is TScan Therapeutics annual D&A year-on-year change?
Over the past year, TCRX annual depreciation & amortization has changed by +$224.00 K (+4.36%)
What is TScan Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of TCRX is $1.03 M
What is the all time high quarterly D&A for TScan Therapeutics?
TScan Therapeutics all-time high quarterly depreciation & amortization is $1.50 M
What is TScan Therapeutics quarterly D&A year-on-year change?
Over the past year, TCRX quarterly depreciation & amortization has changed by -$259.00 K (-20.14%)
What is TScan Therapeutics TTM depreciation & amortization?
The current TTM D&A of TCRX is $4.68 M
What is the all time high TTM D&A for TScan Therapeutics?
TScan Therapeutics all-time high TTM depreciation & amortization is $5.57 M
What is TScan Therapeutics TTM D&A year-on-year change?
Over the past year, TCRX TTM depreciation & amortization has changed by -$888.00 K (-15.96%)